Wednesday, October 7, 2020

24 hours only: $1 a week. Subscribe now.

Take advantage of this special rate on reporting that makes sense of the world.
 
The New York Times View in Browser
 
 
 
THE POP-UP SALE | Subscribe for $1 a week. |  24 HOURS ONLY
 
 
 
VIEW OFFER
 
 
 
 
 
 
Subscribe to clear-eyed reporting on the topics that matter to you, with this special offer on journalism that emphasizes the facts.
 
Subscribe for $1 a week.
24 hours only.
 
 
 
VIEW OFFER
 
 
 
Cancel anytime.
 
 
 
Interested in print? Get 50% off for one year.
 
 
No commitment required. Cancel anytime.
Offer expires October 8, 2020, 5 p.m. E.T. Your payment method will automatically be charged in advance every four weeks. For a Basic Digital Access Subscription, you will be charged the introductory offer rate of $4 every four weeks for the introductory period of one year, and thereafter will be charged the standard rate of $17 every four weeks until you cancel. Home Delivery offers represent 50% off the standard rates for Home Delivery for one year and are not available for current subscribers. Home Delivery prices vary according to location and delivery frequency. All subscriptions renew automatically. You can cancel anytime. The Basic Digital Access Subscription does not include e-reader editions (Kindle, Nook, etc.), NYT Games (the Crossword) or NYT Cooking. Mobile apps are not supported on all devices. These offers are not available for current subscribers. Other restrictions and taxes may apply. Offers and pricing are subject to change without notice.
 
This email was sent to edwardlorilla1986.paxforex@blogger.com
 
Account Login | Help Center
Attn.: Customer Service, P.O. Box 8041, Davenport, IA 52808-8041
 
Terms of Service | Privacy Policy | California Notices | Unsubscribe
 
©2020 The New York Times Company | 620 Eighth Ave., New York, NY 10018
 
 
                                                           

No comments:

Post a Comment

Get Your Updated COVID-19 Shot With TRICARE

Learn why you should get the updated COVID-19 vaccine ...